JP2022524992A5 - - Google Patents

Info

Publication number
JP2022524992A5
JP2022524992A5 JP2021552603A JP2021552603A JP2022524992A5 JP 2022524992 A5 JP2022524992 A5 JP 2022524992A5 JP 2021552603 A JP2021552603 A JP 2021552603A JP 2021552603 A JP2021552603 A JP 2021552603A JP 2022524992 A5 JP2022524992 A5 JP 2022524992A5
Authority
JP
Japan
Application number
JP2021552603A
Other languages
Japanese (ja)
Other versions
JP7727547B2 (ja
JPWO2020178743A5 (https=
JP2022524992A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/051812 external-priority patent/WO2020178743A1/en
Publication of JP2022524992A publication Critical patent/JP2022524992A/ja
Publication of JP2022524992A5 publication Critical patent/JP2022524992A5/ja
Publication of JPWO2020178743A5 publication Critical patent/JPWO2020178743A5/ja
Application granted granted Critical
Publication of JP7727547B2 publication Critical patent/JP7727547B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021552603A 2019-03-04 2020-03-03 T細胞受容体及びその使用方法 Active JP7727547B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962813650P 2019-03-04 2019-03-04
US62/813,650 2019-03-04
PCT/IB2020/051812 WO2020178743A1 (en) 2019-03-04 2020-03-03 T cell receptors and methods of use thereof

Publications (4)

Publication Number Publication Date
JP2022524992A JP2022524992A (ja) 2022-05-11
JP2022524992A5 true JP2022524992A5 (https=) 2023-03-13
JPWO2020178743A5 JPWO2020178743A5 (https=) 2023-03-13
JP7727547B2 JP7727547B2 (ja) 2025-08-21

Family

ID=72337378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021552603A Active JP7727547B2 (ja) 2019-03-04 2020-03-03 T細胞受容体及びその使用方法

Country Status (13)

Country Link
US (1) US20220168346A1 (https=)
EP (1) EP3935171A4 (https=)
JP (1) JP7727547B2 (https=)
KR (1) KR20210144739A (https=)
CN (1) CN113785064B (https=)
AU (1) AU2020231928A1 (https=)
BR (1) BR112021017404A2 (https=)
CA (1) CA3132435A1 (https=)
IL (1) IL286042A (https=)
MX (1) MX2021010538A (https=)
SG (1) SG11202109594PA (https=)
TW (1) TWI877145B (https=)
WO (1) WO2020178743A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7748284B2 (ja) 2019-03-04 2025-10-02 ユニバーシティー ヘルス ネットワーク T細胞受容体及びその使用方法
MX2021010541A (es) 2019-03-04 2021-12-15 Univ Health Network Receptores de linfocitos t y metodos de uso de estos.
CN113795586B (zh) 2019-03-25 2026-03-27 大学健康网络 T细胞受体及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1064022A4 (en) * 1998-03-13 2004-09-29 Epimmune Inc HLA BINDING PROTEINS AND THEIR USE
AU2008206442B2 (en) * 2007-01-12 2012-10-18 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services gp100-specific T cell receptors and related materials and methods of use
US9051391B2 (en) * 2007-06-11 2015-06-09 Takara Bio Inc. Method for expression of specific gene
WO2010037395A2 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
US10441644B2 (en) * 2015-05-05 2019-10-15 The Regents Of The University Of California H3.3 CTL peptides and uses thereof
CN110139873A (zh) * 2016-10-03 2019-08-16 朱诺治疗学股份有限公司 Hpv特异性结合分子

Similar Documents

Publication Publication Date Title
JP2022527267A5 (https=)
JP2022523971A5 (https=)
JP2022524992A5 (https=)
CN305528261S (https=)
CN305579023S (https=)
CN305739079S (https=)
CN305536939S (https=)
CN305536773S (https=)
CN305535989S (https=)
CN305534541S (https=)
CN305534466S (https=)
CN305532146S (https=)
CN305740597S (https=)
CN305532118S (https=)
CN305531689S (https=)
CN305529680S (https=)
CN305528364S (https=)
CN305528231S (https=)
CN305527950S (https=)
CN305739108S (https=)
CN306145656S (https=)
CN306046099S (https=)
CN305991953S (https=)
CN305990600S (https=)
CN305958543S (https=)